A Novel Pipeline for Identification and Prioritization of Gene Fusions in Patient-derived Xenografts of Metastatic Colorectal Cancer

Paciello Giulia, Andrea Acquaviva, Consalvo Petti, Claudio Isella, Enzo Medico, Elisa Ficarra

2014

Abstract

Metastatic spread to the liver is a frequent complication of colorectal cancer (CRC), occurring in almost half of the cases, for which personalized treatment strategies are highly desirable. To this aim, it has been proven that patient-derived mouse xenografts (PDX) of liver-metastatic CRC can be used to discover new therapeutic targets and determinants of drug resistance. To identify gene fusions in RNA-Seq data obtained from such PDX samples, we propose a novel pipeline that tackles the following issues: (i) discriminating human from murine RNA, to filter out transcripts contributed by the mouse stroma that supports the PDX; (ii) increasing sensitivity in case of suboptimal RNA-Seq coverage; (iii) prioritizing the detected chimeric transcripts by molecular features of the fusion and by functional relevance of the involved genes; (iv) providing appropriate sequence information for subsequent validation of the identified fusions. The pipeline, built on top of Chimerascan(R.Iyer, 2011) and deFuse(McPherson, 2011) aligner tools, was successfully applied to RNASeq data from 11 PDX samples. Among the 299 fusion genes identified by the aforementioned softwares, five were selected since passed all the filtering stages implemented into the proposed pipeline resulting as biologically relevant fusions. Three of them were experimentally confirmed.

References

  1. Aaron, R. (2009). Bedtools: a flexible suite of utilities for comparing genomic features. Bioinformatics.
  2. Abate, F. (2012). Bellerophontes: an rna-seq data analysis framework for chimeric transcripts discovery based on accurate fusion model. Bioinformatics.
  3. Aman, P. (1999). Fusion genes in solid tumors. Semin Cancer Biology.
  4. Ansorge, W. (2009). Next-generation dna sequencing techniques. New Biotechnology.
  5. Bertotti, A. (2011). A molecularly annotated platform of patient-derived xenografts ('xenopatients') identifies her2 as an effective therapeutic target in cetuximabresistant colorectal cancer. Cancer Discovery.
  6. Carrara, M. (2013). State-of-the-art fusion-finder algorithms sensitivity and specificity. BioMed Research International.
  7. Conway, T. (2012). Xenome-a tool for classifying reads from xenograft samples. Bioinformatics.
  8. Cunningham, D. (2010). Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review. Colorectal Cancer.
  9. Edwards, P. (2010). Fusion genes and chromosome translocations in the common epithelial cancers. The Journ. of Pathology.
  10. Hanahan, D. (2000). The hallmarks of cancer. Cell.
  11. Langmead, B. (2009). Ultrafast and memory-efficient alignment of short dna sequences to the human genome. Genome Biology.
  12. Li, H. (2009). The sequence alignment/map (sam) format and samtools. Bioinformatics.
  13. Maher, C. (2009). Chimeric transcript discovery by pairedend transcriptome sequencing. PNAS.
  14. Mardis, E. (2008). The impact of next-generation sequencing technology on genetics. Trends in genetics.
  15. McPherson, A. (2011). defuse: An algorithm for gene fusion discovery in tumor rna-seq data. PLoS Computational Biology.
  16. Metzker, M. (2010). Sequencing technologies - the next generation. Nature Reviews Genetics.
  17. Mitelman, F. (2007). The impact of translocations and gene fusions on cancer causation. Nature Reviews.Cancer.
  18. Ozsolak, F. (2011). Rna sequencing: advances, challenges and opportunities. Nat Rev Genet.
  19. R.Iyer (2011). Chimerascan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics.
  20. Rossello, F. (2013). Next-generation sequence analysis of cancer xenograft models. PLoS ONE.
  21. Siena, S. (2009). Biomarkers predicting clinical outcome of epidermal growth factor receptortargeted therapy in metastatic colorectal cancer. JNCI.
  22. Simon, A. (2010). Cosmic: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Research.
  23. Valdes, C. (2013). Characteristics of cross-hybridization and cross-alignment of expression in pseudoxenograft samples by rna-seq and microarrays. Journal of Clinical Bioinformatics.
  24. Walther, A. (2000). Genetic prognostic and predictive markers in colorectal cancer. Nature Reviews.Cancer.
Download


Paper Citation


in Harvard Style

Giulia P., Acquaviva A., Petti C., Isella C., Medico E. and Ficarra E. (2014). A Novel Pipeline for Identification and Prioritization of Gene Fusions in Patient-derived Xenografts of Metastatic Colorectal Cancer . In Proceedings of the International Conference on Bioinformatics Models, Methods and Algorithms - Volume 1: BIOINFORMATICS, (BIOSTEC 2014) ISBN 978-989-758-012-3, pages 142-148. DOI: 10.5220/0004799401420148


in Bibtex Style

@conference{bioinformatics14,
author={Paciello Giulia and Andrea Acquaviva and Consalvo Petti and Claudio Isella and Enzo Medico and Elisa Ficarra},
title={A Novel Pipeline for Identification and Prioritization of Gene Fusions in Patient-derived Xenografts of Metastatic Colorectal Cancer},
booktitle={Proceedings of the International Conference on Bioinformatics Models, Methods and Algorithms - Volume 1: BIOINFORMATICS, (BIOSTEC 2014)},
year={2014},
pages={142-148},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0004799401420148},
isbn={978-989-758-012-3},
}


in EndNote Style

TY - CONF
JO - Proceedings of the International Conference on Bioinformatics Models, Methods and Algorithms - Volume 1: BIOINFORMATICS, (BIOSTEC 2014)
TI - A Novel Pipeline for Identification and Prioritization of Gene Fusions in Patient-derived Xenografts of Metastatic Colorectal Cancer
SN - 978-989-758-012-3
AU - Giulia P.
AU - Acquaviva A.
AU - Petti C.
AU - Isella C.
AU - Medico E.
AU - Ficarra E.
PY - 2014
SP - 142
EP - 148
DO - 10.5220/0004799401420148